KEAP1 and TP53 Mutations in Lung Cancer: More Is Better. Reply to: "Survival Analysis of TP53 Co-Mutations Should Be Interpreted More Cautiously"

J Thorac Oncol. 2022 Mar;17(3):e40-e41. doi: 10.1016/j.jtho.2021.12.001.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Kelch-Like ECH-Associated Protein 1 / genetics
  • Kelch-Like ECH-Associated Protein 1 / metabolism
  • Lung Neoplasms* / genetics
  • Mutation
  • NF-E2-Related Factor 2 / genetics
  • Prognosis
  • Survival Analysis
  • Tumor Suppressor Protein p53 / genetics

Substances

  • KEAP1 protein, human
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • TP53 protein, human
  • Tumor Suppressor Protein p53